These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24192302)

  • 1. Polymorphisms in serotonergic pathways influence the outcome of antidepressant therapy in psychiatric inpatients.
    Staeker J; Leucht S; Laika B; Steimer W
    Genet Test Mol Biomarkers; 2014 Jan; 18(1):20-31. PubMed ID: 24192302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study.
    Popp J; Leucht S; Heres S; Steimer W
    Pharmacogenomics; 2006 Mar; 7(2):159-66. PubMed ID: 16515395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicide ideators and attempters with schizophrenia--the role of 5-HTTLPR, rs25531, and 5-HTT VNTR Intron 2 variants.
    Božina N; Jovanović N; Podlesek A; Rojnić Kuzman M; Kudumija Slijepčević M; Roguljić A; Dimitrović A; Božina T; Lovrić J; Ljubić H; Medved V
    J Psychiatr Res; 2012 Jun; 46(6):767-73. PubMed ID: 22520017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and the serotonin transporter in late-life depression.
    Gerretsen P; Pollock BG
    Expert Opin Drug Metab Toxicol; 2008 Dec; 4(12):1465-78. PubMed ID: 19040324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.
    Kato M; Fukuda T; Wakeno M; Fukuda K; Okugawa G; Ikenaga Y; Yamashita M; Takekita Y; Nobuhara K; Azuma J; Kinoshita T
    Neuropsychobiology; 2006; 53(4):186-95. PubMed ID: 16874005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.
    Shiroma PR; Geda YE; Mrazek DA
    Pharmacogenomics; 2010 Sep; 11(9):1305-30. PubMed ID: 20860469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
    Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
    Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
    Serretti A; Benedetti F; Zanardi R; Smeraldi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.
    Lohoff FW; Aquino TD; Narasimhan S; Multani PK; Etemad B; Rickels K
    Pharmacogenomics J; 2013 Feb; 13(1):21-6. PubMed ID: 22006095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic genes and depressive disorder in acute coronary syndrome: The Korean depression in ACS (K-DEPACS) study.
    Kim JM; Stewart R; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Park SW; Kim YH; Yoon JS
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):882-8. PubMed ID: 25772786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low level of harm avoidance is associated with serotonin transporter functional haplotype in alcohol-dependent individuals.
    Koller G; Zill P; Skoruppa T; Bondy B; Preuss UW; Soyka M
    Psychiatr Genet; 2008 Apr; 18(2):59-63. PubMed ID: 18349696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: pharmacogenetic, endocrine and psychobehavioral results.
    Wong WM; Hasemann S; Schwarz M; Zill P; Koller G; Soyka M; Preuss UW
    Pharmacopsychiatry; 2008 Mar; 41(2):72-8. PubMed ID: 18311688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter gene polymorphisms: effect on serotonin transporter availability in the brain of suicide attempters.
    Bah J; Lindström M; Westberg L; Mannerås L; Ryding E; Henningsson S; Melke J; Rosén I; Träskman-Bendz L; Eriksson E
    Psychiatry Res; 2008 Apr; 162(3):221-9. PubMed ID: 18314311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia.
    Kaiser R; Tremblay PB; Schmider J; Henneken M; Dettling M; Müller-Oerlinghausen B; Uebelhack R; Roots I; Brockmöller J
    Mol Psychiatry; 2001 Mar; 6(2):179-85. PubMed ID: 11317220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic and BDNF genes associated with depression 1 week and 1 year after mastectomy for breast cancer.
    Kim JM; Kim SW; Stewart R; Kim SY; Shin IS; Park MH; Yoon JH; Lee JS; Park SW; Kim YH; Yoon JS
    Psychosom Med; 2012 Jan; 74(1):8-15. PubMed ID: 22210241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy.
    Wilkie MJ; Smith G; Day RK; Matthews K; Smith D; Blackwood D; Reid IC; Wolf CR
    Pharmacogenomics J; 2009 Feb; 9(1):61-70. PubMed ID: 18253134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of 5-HTT and HTR1A gene polymorphisms in treatment responses to mirtazapine in patients with major depressive disorder.
    Chang HS; Lee HY; Cha JH; Won ES; Ham BJ; Kim B; Lee MS
    J Clin Psychopharmacol; 2014 Aug; 34(4):446-54. PubMed ID: 24911443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.